<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>420 patients with <z:e sem="disease" ids="C0338437" disease_type="Disease or Syndrome" abbrv="">cerebral cysticercosis</z:e>, including 97 with intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo>, were treated by praziquantel 30-50 mg/kg a day, 7-10 days a course </plain></SENT>
<SENT sid="1" pm="."><plain>Of the 420 patients, 252, 144 and 24 were treated for one, two and three courses respectively </plain></SENT>
<SENT sid="2" pm="."><plain>1-6 years' follow-up study showed 366 were completely recovered (87.14%) and 399 had effect (95.00%); 12 had inefficacy and 9 died (5.00%) </plain></SENT>
<SENT sid="3" pm="."><plain>It is believed that the serious <z:hpo ids='HP_0011009'>acute</z:hpo> allergic reactions might be eliminated by "desensitization" of a small dose of praziquantel; intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> can be lowered by intrathecal injection of <z:chebi fb="0" ids="41879">dexamethasone</z:chebi>; and ventricular and intra-ocular <z:e sem="disease" ids="C0010678" disease_type="Disease or Syndrome" abbrv="">cysticercosis</z:e> can also be treated by praziquantel </plain></SENT>
</text></document>